Weekly Analysts Ratings Changes for Jazz Pharmaceuticals (JAZZ)
News Source : ETF Daily News
News Summary
- CEO Bruce C
- Cozadd sold 2,000 shares of Jazz Pharmaceuticals stock in a transaction dated Monday, December 2nd
- The shares were sold at an average price of $121
- 17, for a total transaction of $242,340
- 00
- Following the completion of the sale, the chief executive officer now directly owns 427,025 shares in the company, valued at $51,742,619
- 25
- The sale was disclosed in a filing with the SEC, which is available through the SEC website
Several brokerages have updated their recommendations and price targets on shares of Jazz Pharmaceuticals (NASDAQ JAZZ) in the last few weeks12/12/2024 Jazz Pharmaceuticals had its ove [+6096 chars]
-limited-logo-1200x675.png?v=20240522095703&w=240&h=240&zc=2){kind=logo}
Never miss a story from us, subscribe to our newsletter